Suvro Sankha Datta: Developing Blood Group Genotyping Platform Using a Gold-Oligo
Suvro Sankha Datta, Senior Consultant and Head Transfusion Medicine at Tata Medical Center, shared a post on LinkedIn about a recent article he and his colleague co-authored, published in Science Factors, adding:
“Check the recent editorial published in the Science Factors September issue on developing a rapid blood group genotyping platform using a Gold-oligo nanonet assembly to detect the RHD gene directly without fluorescence and PCR amplification.
All credit goes to Parikshit Moitra and his team.
Currently it is at the proof-of-concept stage and a long way to go before making it a clinically deployable model.”
Title: Engineering Gold Nanoparticles for Smarter Blood Typing
Authors: Suvro Sankha Datta, Parikshit Moitra
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke